DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment

No abstract is available for this paper.

• Publication year

  2009

• Venue

  World Journal of Surgery

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00268-008-9840-1PMID 19034564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis

  2008cited by this paper
• DNA repair deficiency as a therapeutic target in cancer.

  2008cited by this paper
• First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers

  2007cited by this paper
• The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

  2007cited by this paper
• Two faces of p53: aging and tumor suppression

  2007cited by this paper
• Profiling of UV-induced ATM/ATR signaling pathways

  2007cited by this paper
• Targeted cancer therapies based on the inhibition of DNA strand break repair

  2007cited by this paper
• DNA strand break repair and human genetic disease.

  2007cited by this paper
• Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology

  2007cited by this paper
• Mutator pathways unleashed by epigenetic silencing in human cancer.

  2007cited by this paper
• MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

  2006cited by this paper
• First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM).

  2006cited by this paper
• Nucleotide excision repair and cancer

  2006cited by this paper
• BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.

  2006cited by this paper
• The complexity of p53 stabilization and activation

  2006cited by this paper
• Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

  2006cited by this paper
• Emerging cancer therapeutic opportunities target DNA-repair systems.

  2006cited by this paper
• Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.

  2006cited by this paper
• ATM signaling and 53BP1.

  2005cited by this paper
• First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• PARP inhibitors for cancer therapy

  2005cited by this paper
• Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  2005cited by this paper
• Cancer in xeroderma pigmentosum and related disorders of DNA repair

  2005cited by this paper
• Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo.

  2005cited by this paper
• ATM Activation in Normal Human Tissues and Testicular Cancer

  2005cited by this paper
• The Concept of Synthetic Lethality in the Context of Anticancer Therapy

  2005cited by this paper
• Initiating cellular stress responses.

  2004cited by this paper
• 53BP1, an activator of ATM in response to DNA damage.

  2004cited by this paper
• The cellular response to general and programmed DNA double strand breaks.

  2004cited by this paper
• Running interference: pace picks up on synthetic lethality research.

  2004cited by this paper
• Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From

  2004cited by this paper
• G2 checkpoint abrogators as anticancer drugs.

  2004cited by this paper
• Targeting the checkpoint kinases: chemosensitization versus chemoprotection

  2004cited by this paper
• Cell death: critical control points.

  2004cited by this paper
• Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.

  2004cited by this paper
• p53 Moves to Mitochondria: A Turn on the Path to Apoptosis

  2004cited by this paper
• Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.

  2003cited by this paper
• Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.

  2003cited by this paper
• DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

  2003cited by this paper
• The cellular response to DNA double-strand breaks: defining the sensors and mediators.

  2003cited by this paper
• Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

  2003influential reference
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• Chk1‐deficient tumour cells are viable but exhibit multiple checkpoint and survival defects

  2003cited by this paper
• Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents*

  2003cited by this paper
• The Fanconi road to cancer.

  2003cited by this paper
• Decision making by p53: life, death and cancer

  2003cited by this paper
• Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes

  2003cited by this paper
• Poly(ADP-ribose) polymerase inhibitors.

  2003cited by this paper
• Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation*

  2003cited by this paper
• p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice

  2003cited by this paper
• Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer

  2002influential reference
• Regulation of G2/M events by Cdc25A through phosphorylation‐dependent modulation of its stability

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints

  2002influential reference
• Interfaces Between the Detection, Signaling, and Repair of DNA Damage

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling

  2002cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• Genotoxic and non-genotoxic pathways of p53 induction.

  2001cited by this paper
• Genome maintenance mechanisms for preventing cancer

  2001cited by this paper
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• DNA helicases, genomic instability, and human genetic disease.

  2000cited by this paper
• Death Signal-induced Localization of p53 Protein to Mitochondria

  2000cited by this paper
• Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems.

  2000cited by this paper
• Rapid destruction of human Cdc25A in response to DNA damage.

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

  2000cited by this paper
• BRCA1 and BRCA2.

  2000cited by this paper
• Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

  1999cited by this paper
• DNA double-strand break repair.

  1999influential reference
• DNA double-strand break repair.

  1999cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Instability and decay of the primary structure of DNA

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper

• Multi-omics analysis and functional validation of CHEK1 as an independent prognostic biomarker in Pancreatic cancer

  2026cites this paper
• Characterization of new non-ATP dependent inhibitors of TLK1 as potential molecules for treating prostate cancer.

  2025cites this paper
• Targeting ATR Kinase as a Strategy for Canine Lymphoma and Leukaemia Treatment.

  2024cites this paper
• A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer

  2023cites this paper
• Cellular Stress Promotes Cellular Suicide: Review Article

  2023cites this paper
• The mechanistic role of cardiac glycosides in DNA damage response and repair signaling

  2023influential citation
• Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges

  2023cites this paper
• Role of condensates in modulating DNA repair pathways and its implication for chemoresistance

  2023cites this paper
• PARP1 Upregulation in Recurrent Oral Cancer and Treatment Resistance

  2022cites this paper
• The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions.

  2022cites this paper
• Anticancer potential of metformin: focusing on gastrointestinal cancers

  2021cites this paper
• Phosphatase POPX2 interferes with cell cycle by interacting with Chk1

  2020cites this paper
• Up and down-regulation of mRNA in the cytotoxicity and genotoxicity of Plumbagin in HepG2/C3A.

  2020cites this paper
• Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors

  2020cites this paper
• Kinesin Kif2C in regulation of DNA double strand break dynamics and repair

  2020cites this paper
• In vitro lung toxicity of indoor PM10 from a stove fueled with different biomasses.

  2019cites this paper
• Inhibition of Caspase-2 Translation by the mRNA Binding Protein HuR: A Novel Path of Therapy Resistance in Colon Carcinoma Cells?

  2019cites this paper
• Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib

  2019cites this paper
• Nucleolar targeting in combination with radiation for cancer therapy.

  2019cites this paper
• The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens

  2019cites this paper
• Computational modelling of protein-protein and cell-cell interaction across multiple scales

  2018cites this paper
• 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

  2018cites this paper
• Molecular Features and Their Clinical Implications on Gastric Adenocarcinoma

  2018cites this paper
• 5 Shared Regulatory Motifs in Promoters of Human DNA Repair Genes

  2018cites this paper
• Fine particle matters induce DNA damage and G2/M cell cycle arrest in human bronchial epithelial BEAS-2B cells

  2017cites this paper
• Shared Regulatory Motifs in Promoters of Human DNA Repair Genes

  2017cites this paper
• Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR).

  2017cites this paper
• Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.

  2017cites this paper
• Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer

  2017cites this paper
• Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.

  2017cites this paper
• Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine

  2016cites this paper
• Pluripotent Stem Cells and DNA Damage Response to Ionizing Radiations

  2016cites this paper
• Uridine homeostatic disorder leads to DNA damage and tumorigenesis.

  2016cites this paper
• Protective effects of Rg2 against UVB-induced DNA damage in HaCaT cells is dependent on p53 expression

  2016cites this paper
• The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis

  2016cites this paper
• Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells

  2016cites this paper
• “Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors

  2016influential citation
• The Inhibition of Chk1/Chk2 and Wee-1 Kinases as a Promising Therapy for the Treatment of Adult Acute Lymphoblastic Leukemia

  2016cites this paper
• The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells

  2015cites this paper
• ATM gene mutations in sporadic breast cancer patients from Brazil

  2015cites this paper
• ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway

  2015cites this paper
• The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity

  2015influential citation
• 2 SUPERVISOR Principal Investigator

  2015cites this paper
• Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

  2015cites this paper
• Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.

  2015cites this paper
• RAD51C IS A TUMOR SUPPRESSOR IN MAMMARY AND SEBACEOUS GLANDS

  2015cites this paper
• Résistance aux inhibiteurs de PARP

  2015cites this paper
• Filia Is an ESC-Specific Regulator of DNA Damage Response and Safeguards Genomic Stability.

  2015cites this paper
• HaCaT 세포에서 자외선 B에 의해 유도된 DNA 상해반응에 대한 복분자와 쑥 추출물의 효과

  2014cites this paper
• Moniliformediquinone induces in vitro and in vivo antitumor activity through glutathione involved DNA damage response and mitochondrial stress in human hormone refractory prostate cancer.

  2014cites this paper
• Comparison of cytotoxicity and genotoxicity of 4-hydroxytamoxifen in combination with Tualang honey in MCF-7 and MCF-10A cells

  2014cites this paper
• The progress in the mechanistic studies of maintaining replication fork stability in eukaryotic cells

  2014cites this paper
• Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex

  2014cites this paper
• Radioprotection of normal tissue cells

  2014cites this paper
• Mecanismos de reparo de DNA envolvidos com lesões induzidas por agente alquilante (Nimustina) em células humanas e sua associação com a resistência de gliomas.

  2014cites this paper
• Characterization of TPX2 phosphorylation at Threonine 72 in Human cancer cells

  2014cites this paper
• Effects of Rubus coreanus and Artemisia princeps Extracts on the Ultraviolet B-Induced DNA Damage Responses in HaCaT Cells

  2014cites this paper
• The progress in the mechanistic studies of maintaining replication fork stability in eukaryotic cells

  2014cites this paper
• Characterisation of caspase-2 function in the DNA damage response and tumour suppression.

  2014cites this paper
• Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory

  2014cites this paper
• Bufalin induces cell death in human lung cancer cells through disruption of DNA damage response pathways.

  2014cites this paper
• FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.

  2013cites this paper
• Working hard for recovery: mitotic kinases in the DNA damage checkpoint

  2013cites this paper
• Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A).

  2013cites this paper
• Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53‐dependent and ‐independent signaling pathways

  2013cites this paper
• Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway.

  2013cites this paper
• Radioactive 125I Seed Inhibits the Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Triggering DNA Damage and Inactivating VEGF-A/ERK Signaling

  2013cites this paper
• Zinc finger protein 668 interacts with Tip60 to promote H2AX acetylation after DNA damage

  2013cites this paper
• The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

  2013cites this paper
• Toxic Effect of Silica Nanoparticles on Endothelial Cells through DNA Damage Response via Chk1-Dependent G2/M Checkpoint

  2013cites this paper
• DNA Damage Response and Breast Cancer: An Overview

  2012cites this paper
• Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.

  2012cites this paper
• PARP1 polymorphisms increase the risk of gastric cancer in a Chinese population.

  2012cites this paper
• Modulation of apoptosis and signalling in cancer cells after treatment with epigenetic modulators

  2012cites this paper
• Estudi dels mecanismes de reparació del dany oxidatiu en fase replicativa del DNA en humans: L’Anèmia de Fanconi i PCNA

  2012cites this paper
• Chromodomain helicase DNA‐binding protein 2 affects the repair of X‐ray and UV‐Induced DNA damage

  2012cites this paper
• Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia

  2012cites this paper
• Selective tumor killing based on specific DNA-damage response deficiencies

  2012cites this paper
• PARP1 Polymorphisms Increase the Risk of Gastric Cancer in a Chinese Population

  2012cites this paper
• Effects of Paprika Extract and Its Components on Cell Death and Expression of p53 and GADD45 Genes in Ultraviolet B- Exposed HaCaT Cells

  2011influential citation
• FUNCTION OF ZNF668 IN CANCER DEVELOPMENT

  2011cites this paper
• The Role of Aneuploidy in the Malignant Transformation of Human Bladder Epithelial Cells

  2011cites this paper
• Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle.

  2011cites this paper
• Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.

  2011cites this paper
• DNA Repair, Cancer and Cancer Therapy - The Current State of Art

  2011cites this paper
• Oxidative DNA damage is a preliminary step during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

  2011cites this paper
• Identification of Poly (ADP-ribose) Polymerase-1 (PARP-1) as a Novel Krüppel-like Factor 8-interacting and -regulating Protein*

  2011cites this paper
• Ataxia Telangiectasia and Rad3-Related Overexpressing Cancer Cells Induce Prolonged G2 Arrest and Develop Resistance to Ionizing Radiation

  2011influential citation
• The Pennsylvania State University The Graduate School Intercollege Graduate Degree Program in Genetics EXPRESSION AND FUNCTION OF THE TUMOR SUPPRESSOR CANDIDATE HTRA1 IN HUMAN BREAST EPITHELIAL CELLS

  2011cites this paper
• Raf-1 kinase inhibitor protein modulation of the cellular response to chemotherapeutic drugs and PDE5 inhibitors.

  2011cites this paper
• Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8+ T Cells with Augmented Ability to Generate Long-Lasting Memory Cells

  2011cites this paper
• DNA Repair, Cancer and Cancer Therapy

  2011cites this paper
• Shared Regulatory Motifs in Promoters of Human DNA Repair Genes

  2011cites this paper
• The characterization of atm-1 in Caenorhabditis elegans

  2011cites this paper
• Targeting the DNA double strand breaks repair for cancer therapy.

  2010cites this paper
• Nucleotide Excision repair pathway modulating both cancer risk and therapy

  2010cites this paper
• Chk2 down-regulation by promoter hypermethylation in human bulk gliomas.

  2010cites this paper
• Functional Analysis of Chromodomain Helicase DNA Binding Protein 2(CHD2) mediated Genomic Stability

  2010cites this paper
• Genetic determinants at the interface of cancer and neurodegenerative disease

  2010cites this paper
• Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tract.

  2010cites this paper